Drug Type CAR-NKT |
Synonyms API 192 |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Malignant Neoplasm | Preclinical | US | 05 Dec 2023 | |
B-Cell Malignant Neoplasm | Preclinical | US | Appia Bio, Inc.Startup | 05 Dec 2023 |
Non-Hodgkin Lymphoma | Preclinical | US | Appia Bio, Inc.Startup | 05 Dec 2023 |
Non-Hodgkin Lymphoma | Preclinical | US | 05 Dec 2023 |